EUVIMEDAtrasti EUVIMED
Crossref

Ginsenoside CK cooperates with bone mesenchymal stem cells to enhance angiogenesis post‐stroke via GLUT1 and HIF ‐1α/ VEGF pathway

Xijun Chen iD, Wenqi Qian, Ying Zhang, Peiqi Zhao, Xiangxiang Lin, Su Yang, Qichuan Zhuge, Haoqi Ni

Phytotherapy Research · 2024

DOI: 10.1002/ptr.8235 ↗

At a glance

Journal article in Phytotherapy Research, 2024. Written by Xijun Chen and 7 co-authors. Institution: Zhejiang Provincial Key Laboratory of Aging and Neurological Disorder Research, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou,…. Major MEDLINE topics: Ginsenosides, Mesenchymal Stem Cells, Glucose Transporter Type 1, Hypoxia-Inducible Factor 1, alpha Subunit. Cited 24 times so far (Crossref); 53 references. Funded by: the Science Foundation of Zhejiang Province, the National Natural Science Foundation of China, the Basic Scientific Research Project of Wenzhou Science and Technology Bureau.

SantraukaSubjectsBibliografiniai duomenysCiteRelated studies

Abstract (original language)

The transplantation of bone marrow mesenchymal stem cells (MSCs) in stroke is hindered by the restricted rates of survival and differentiation. Ginsenoside compound K (CK), is reported to have a neuroprotective effect and regulate energy metabolism. We applied CK to investigate if CK could promote the survival of MSCs and differentiation into brain microvascular endothelial‐like cells (BMECs), thereby alleviating stroke symptoms. Therefore, transwell and middle cerebral artery occlusion (MCAO) models were used to mimic oxygen and glucose deprivation (OGD) in vitro and in vivo, respectively. Our results demonstrated that CK had a good affinity for GLUT1, which increased the expression of GLUT1 and the production of ATP, facilitated the proliferation and migration of MSCs, and activated the HIF‐1α/VEGF signaling pathway to promote MSC differentiation. Moreover, CK cooperated with MSCs to protect BMECs, promote angiogenesis and vascular density, enhance neuronal and astrocytic proliferation, thereby reducing infarct volume and consequently improving neurobehavioral outcomes. These results suggest that the synergistic effects of CK and MSCs could potentially be a promising strategy for stroke.

Subjects

MeSH terms (MEDLINE)

GinsenosidesMesenchymal Stem CellsGlucose Transporter Type 1Hypoxia-Inducible Factor 1, alpha SubunitVascular Endothelial Growth Factor AStrokeAnimalsMaleCell DifferentiationSignal TransductionRatsRats, Sprague-DawleyCell ProliferationNeovascularization, PhysiologicAngiogenesis

Author keywords

GLUT1angiogenesisbone mesenchymal stem cellginsenoside compound Kstroke

Substances

GinsenosidesGlucose Transporter Type 1Hypoxia-Inducible Factor 1, alpha SubunitVascular Endothelial Growth Factor Aginsenoside compound KSlc2a1 protein, ratHif1a protein, ratvascular endothelial growth factor A, rat

Authors and institutions

  • Zhejiang Provincial Key Laboratory of Aging and Neurological Disorder Research, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
  • Zhejiang-US Joint Laboratory for Aging and Neurological Disease Research, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
  • Department of Neurosurgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.

ORCID profiles: Xijun Chen

Funding

  • the Science Foundation of Zhejiang Province
  • the National Natural Science Foundation of China
  • the Basic Scientific Research Project of Wenzhou Science and Technology Bureau
  • National Natural Science Foundation of China

Cite

APA

Chen, X., Qian, W., Zhang, Y., Zhao, P., Lin, X., Yang, S., Zhuge, Q., & Ni, H. (2024). Ginsenoside CK cooperates with bone mesenchymal stem cells to enhance angiogenesis post‐stroke via GLUT1 and HIF ‐1α/ VEGF pathway. Phytotherapy Research. https://doi.org/10.1002/ptr.8235

Vancouver

Chen X, Qian W, Zhang Y, Zhao P, Lin X, Yang S, et al. Ginsenoside CK cooperates with bone mesenchymal stem cells to enhance angiogenesis post‐stroke via GLUT1 and HIF ‐1α/ VEGF pathway. Phytotherapy Research. 2024. doi:10.1002/ptr.8235

BibTeX
@article{Chen2024,
  author = {Chen, Xijun and Qian, Wenqi and Zhang, Ying and Zhao, Peiqi and Lin, Xiangxiang and Yang, Su and Zhuge, Qichuan and Ni, Haoqi},
  title = {Ginsenoside CK cooperates with bone mesenchymal stem cells to enhance angiogenesis post‐stroke via GLUT1 and HIF ‐1α/ VEGF pathway},
  journal = {Phytotherapy Research},
  year = {2024},
  doi = {10.1002/ptr.8235}
}
Start for free →